Mutations in MLH1, MSH2, MSH6, and PMS2 and/or the epigenetic silencing of MLH1 or MSH2 genes can trigger MMR malfunction, which induces genome instability and promotes cancer (2,3). This evidence concerns the gene MSH2 and cancer.